Woodline Partners’s Freeline Therapeutics Holdings FRLN Stock Holding History
Bought
Maintained
Sold
Other funds holding FRLN
Woodline Partners's FRLN Position: Q1 2022 in Review
Woodline Partners sold out of Freeline Therapeutics Holdings (FRLN) in Q1 2022, closing a stake of 1,729 shares — an estimated $51K sold.
Woodline Partners first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $3.22M in Q3 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.
- Woodline Partners reported no remaining Freeline Therapeutics Holdings position as of Q1 2022 after selling out during the quarter.
- Woodline Partners sold 1,729 Freeline Therapeutics Holdings shares in Q1 2022, an estimated $51K.
- Woodline Partners first reported a position in Freeline Therapeutics Holdings in Q3 2020 and held it in 6 quarters.
- Woodline Partners's Freeline Therapeutics Holdings position peaked at $3.22M in Q3 2020.
- 19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q1 2022.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.